Chang-Ki Min

Chang-Ki Min

Auto-generated profile, based on publicly available information

Chang-Ki Min

Division of Hematology, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, 222 Banpo-daero, Seocho-gu, Seoul 137-701, Republic of Korea

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 June 2014 in BioMed Research International
Verified
Journal Article
Open access
PDF file
HLHo Sup Lee
Ho Sup Lee
KKKihyun Kim
Kihyun Kim
DYDok Hyun Yoon
Dok Hyun Yoon
JKJIN SEOK KIM
JIN SEOK KIM
SBSoo-Mee Bang
Soo-Mee Bang
CMChang-Ki Min
Chang-Ki Min
Waldenström’s macroglobulinemia (WM) is a B-cell proliferative malignancy characterized by immunoglobulin M monoclonal gammopathy and bone marrow infiltration by lymphoplasmacytic cells. Clinical features and cytogenetics of WM in Asia including Republic of Korea remain unclear. Moreover, no study has reported treatment outcomes in patients with WM treated with novel agent combined with conventional chemotherapy. This study investigated clinical features and assessed treatment outcomes with novel agent and conventional chemotherapy in Republic of Korea. Data from all (n=71) patients with newly diagnosed WM at 17 hospitals who received chemotherapy between January 2005 and December 2012 were collected retrospectively. The median age of patients was 66 years (range: 37–92 years) and male to female ratio was 5 : 1. Patients treated with novel agent combined chemotherapy displayed higher overall response rate (ORR) compared to conventional chemotherapy alone (92.9% versus 52.6%,P=0.006). The 5-year overall survival rate was 62.6% (95% confidence interval: 34.73–111.07). Use of novel agents produced higher ORR but survival benefit was not apparent due to the small number of patients and short follow-up duration. Further studies are needed to confirm the efficacy of novel agents in patients with WM.

1 January 2009 in The Korean Journal of Internal Medicine
Verified
Journal Article
Open access
PDF file
HPHyun-Sil Park
Hyun-Sil Park
SCSeok-Goo Cho
Seok-Goo Cho
MPMin-Jung Park
Min-Jung Park
SMSo-Youn Min
So-Youn Min
HCHong-Seok Chang
Hong-Seok Chang
HKHo-Youn Kim
Ho-Youn Kim
Park HS, et al. Korean J Intern Med. 2009 Sep;24(3):252-262. http://dx.doi.org/10.3904/kjim.2009.24.3.252